Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma [3]

ANN-LII CHENG2021-09-012021-09-0119960006-4971https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030059941&doi=10.1182%2fblood.v87.3.1202a.bloodjournal8731202a&partnerID=40&md5=0f2d4a198762f49970c1c1d4755a17cehttps://scholars.lib.ntu.edu.tw/handle/123456789/580492[SDGs]SDG3cyclophosphamide; doxorubicin; ifosfamide; methotrexate; prednisolone; vincristine; cancer chemotherapy; controlled study; disease activity; drug effect; drug efficacy; hepatitis B; human; intravenous drug administration; letter; major clinical study; nonhodgkin lymphoma; priority journal; treatment outcome; treatment planningSteroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma [3]letter10.1182/blood.v87.3.1202a.bloodjournal8731202a85629502-s2.0-0030059941